This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic (0.25-0.5 mg/dose) pens. The contract is a Firm Fixed Price Delivery Order with a total ceiling value of $9,740.97 and an ultimate completion date of September 25, 2024.
AmerisourceBergen, through its Corporate Office Division, has been awarded this contract to supply the DLA with this critical diabetes medication. This award is likely part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Generated 12/24/24, 9:36 AM